 Coagulation-fibrinolysis abnormalities acute chronic phases cerebral thrombosis embolism plasma concentrations fibrinogen plasmin-alpha plasmin inhibitor complex dimer antithrombin III activity patients cerebral thrombosis patients cerebral embolism acute days subacute days chronic equal days periods controls cerebral thrombosis fibrinogen levels stages whereas plasmin-alpha plasmin inhibitor complex dimer levels subacute chronic periods antithrombin III activity acute stage elevation fibrinogen plasmin-alpha plasmin inhibitor complex levels acute stage patients infarct size patients infarct size similar changes patients cerebral embolism results enhanced coagulation exists stages endogenous fibrinolysis subacute chronic periods large proportion patients cerebral thrombosis embolism